Concepedia

Filip Janku

FJ

Statistics

Publications

5

Citations

192

H-Index

5

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Filip Janku is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

2013–2023

5

Publications

5

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Filip Janku, Lorraine Johnson, Daniel D. Karp et al. · Annals of Oncology · 2016 · 92 citations · Full text

, , +7

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis

Ashley Aaroe, Razelle Kurzrock, Gaurav Goyal et al. · Blood Advances · 2023 · 38 citations · Full text

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson precision medicine study.

Apostolia M. Tsimberidou, David S. Hong, Carrie Cartwright et al. · Journal of Clinical Oncology · 2017 · 28 citations

, , +16

Abstract CT107: Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu et al. · Cancer Research · 2023 · 19 citations

, , +23

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes

Haby Henary, David S. Hong, G. S. Falchook et al. · Annals of Oncology · 2013 · 15 citations · Full text

, , +7

1–5 of 5